Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2023

17-06-2023 | Hysterectomy | Brief Report

Variation in hysterectomy prevalence and trends among U.S. States and Territories—Behavioral Risk Factor Surveillance System, 2012–2020

Authors: Sameer V. Gopalani, Sabitha R. Dasari, Emily E. Adam, Trevor D. Thompson, Mary C. White, Mona Saraiya

Published in: Cancer Causes & Control | Issue 10/2023

Login to get access

Abstract

Purpose

We estimated up-to-date state- and territory-level hysterectomy prevalence and trends, which can help correct the population at risk denominator and calculate more accurate uterine and cervical cancer rates.

Methods

We analyzed self-reported data for a population-based sample of 1,267,013 U.S. women aged ≥ 18 years who participated in the Behavioral Risk Factor Surveillance System surveys from 2012 to 2020. Estimates were age-standardized and stratified by sociodemographic characteristics and geography. Trends were assessed by testing for any differences in hysterectomy prevalence across years.

Results

Hysterectomy prevalence was highest among women aged 70–79 years (46.7%) and ≥ 80 years (48.8%). Prevalence was also higher among women who were non-Hispanic (NH) Black (21.3%), NH American Indian and Alaska Native (21.1%), and from the South (21.1%). Hysterectomy prevalence declined by 1.9 percentage points from 18.9% in 2012 to 17.0% in 2020.

Conclusions

Approximately one in five U.S. women overall and half of U.S. women aged ≥ 70 years reported undergoing a hysterectomy. Our findings reveal large variations in hysterectomy prevalence within and between each of the four census regions and by race and other sociodemographic characteristics, underscoring the importance of adjusting epidemiologic measures of uterine and cervical cancers for hysterectomy status.
Appendix
Available only for authorised users
Literature
1.
Fingar KR, Stocks C, Weiss AJ, Steiner CA (2014) Most frequent operating room procedures performed in U.S. hospitals, 2003–2012. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US), Rockville
2.
Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM et al (2008) Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 198(34):e1-7
3.
Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E (2016) Outcomes and postoperative complications after hysterectomies performed for benign compared with malignant indications. Obstet Gynecol 128:467–475CrossRefPubMed
4.
Morgan DM, Kamdar NS, Swenson CW, Kobernik EK, Sammarco AG, Nallamothu B (2018) Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women. Am J Obstet Gynecol 218:425.e1–425.e18
5.
Doll KM, Dusetzina SB, Robinson W (2016) Trends in inpatient and outpatient hysterectomy and oophorectomy rates among commercially insured women in the United States, 2000–2014. JAMA Surg 151:876–877CrossRefPubMedPubMedCentral
6.
Wright MA, Doll KM, Myers E, Carpenter WR, Gartner DR, Robinson WR (2021) Changing trends in Black–White racial differences in surgical menopause: a population-based study. Am J Obstet Gynecol 225:502.e1–502.e13
7.
Robinson WR, Cheng MM, Howard AG, Carpenter WR, Brewster WR, Doll KM (2017) For U.S. Black women, shift of hysterectomy to outpatient settings may have lagged behind White women: a claims-based analysis, 2011–2013. BMC Health Serv Res 17:526
8.
Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF et al (2005) Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues 15:179–186CrossRefPubMed
9.
Temkin SM, Kohn EC, Penberthy L, Cronin KA, Rubinsak L, Dickie LA et al (2018) Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States. Cancer Causes Control 29:427–433CrossRefPubMed
10.
Bower JK, Schreiner PJ, Sternfeld B, Lewis CE (2009) Black-White differences in hysterectomy prevalence: the CARDIA study. Am J Public Health 99:300–307CrossRefPubMedPubMedCentral
11.
Erekson EA, Weitzen S, Sung VW, Raker CA, Myers DL (2009) Socioeconomic indicators and hysterectomy status in the United States, 2004. J Reprod Med 54:553–558PubMedPubMedCentral
12.
Harvey SV, Pfeiffer RM, Landy R, Wentzensen N, Clarke MA (2022) Trends and predictors of hysterectomy prevalence among women in the United States. Am J Obstet Gynecol 227(4):611.e1–611.e12
13.
Temkin SM, Minasian L, Noone AM (2016) The end of the hysterectomy epidemic and endometrial cancer incidence: what are the unintended consequences of declining hysterectomy rates? Front Oncol 6:89CrossRefPubMedPubMedCentral
14.
Rositch AF, Nowak RG, Gravitt PE (2014) Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 120:2032–2038CrossRefPubMed
15.
Adam EE, White MC, Saraiya M (2022) US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates. Cancer Causes Control 33:161–166CrossRefPubMed
16.
Centers for Disease Control and Prevention (2012) Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 61:410–413
17.
Centers for Disease Control and Prevention (2021) Behavioral Risk Factor Surveillance System Survey Data & Documentation
18.
Wright JD, Huang Y, Li AH, Melamed A, Hershman DL (2022) Nationwide estimates of annual inpatient and outpatient hysterectomies performed in the United States. Obstet Gynecol 139:446–448CrossRefPubMed
19.
Laughlin-Tommaso SK (2016) Alternatives to hysterectomy: management of uterine fibroids. Obstet Gynecol Clin North Am 43:397–413CrossRefPubMed
20.
Billow MR, El-Nashar SA (2016) Management of abnormal uterine bleeding with emphasis on alternatives to hysterectomy. Obstet Gynecol Clin North Am 43:415–430CrossRefPubMed
21.
Morgan DM, Kamdar NS, Dalton VK, Swenson CW, Moniz MH, Nallamothu B (2019) Savings with expanding use of the levonorgestrel intrauterine device and fewer benign hysterectomies. Am J Obstet Gynecol 220:116–8.e1CrossRefPubMed
22.
Giuliani E, As-Sanie S, Marsh EE (2020) Epidemiology and management of uterine fibroids. Int J Gynecol Obstet 149:3–9CrossRef
23.
Borah BJ, Nicholson WK, Bradley L, Stewart EA (2013) The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol 209:319.e1–319.e20
24.
Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE (2010) Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol 202:514–521CrossRefPubMedPubMedCentral
25.
Sutton MY, Anachebe NF, Lee R, Skanes H (2021) Racial and ethnic disparities in reproductive health services and outcomes, 2020. Obstet Gynecol 137(2):225–233
26.
Moore AMD (2023) Race, class, caste, disability, sterilisation and hysterectomy. Med Humanit 49:27–37CrossRef
27.
Lawrence J (2000) The Indian Health Service and the sterilization of Native American women. Am Indian Q 24:400–419CrossRefPubMed
28.
Prather C, Fuller TR, Jeffries WLt, Marshall KJ, Howell AV, Belyue-Umole A, et al (2018) Racism, African American Women, and their sexual and reproductive health: a review of historical and contemporary evidence and implications for health equity. Health Equity 2:249–259
29.
VanNoy BN, Bowleg L, Marfori C, Moawad G, Zota AR (2021) Black women’s psychosocial experiences with seeking surgical treatment for uterine fibroids: implications for clinical practice. Womens Health Issues 31:263–270CrossRefPubMedPubMedCentral
30.
Phipps AI, Buist DS (2009) Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 16:576–581CrossRefPubMedPubMedCentral
Metadata
Title
Variation in hysterectomy prevalence and trends among U.S. States and Territories—Behavioral Risk Factor Surveillance System, 2012–2020
Authors
Sameer V. Gopalani
Sabitha R. Dasari
Emily E. Adam
Trevor D. Thompson
Mary C. White
Mona Saraiya
Publication date
17-06-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2023
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01735-6

Other articles of this Issue 10/2023

Cancer Causes & Control 10/2023 Go to the issue

Brief Report

Birth characteristics and risk of Ewing sarcoma

Original Paper

Supplement use and gastric cancer risk in the Southern Community Cohort Study

Original Paper

Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies

Original Paper

Associations of gut microbiome with endogenous estrogen levels in healthy postmenopausal women

Original Paper

Building capacity for collaborative research between basic scientists and underrepresented communities in cancer research

Original Paper

The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits